Literature DB >> 7831346

Tamoxifen for breast cancer prevention.

V C Jordan1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7831346     DOI： 10.3181/00379727-208-43846c

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN： 0037-9727


× No keyword cloud information.
  8 in total

Review 1.  Tamoxifen in postmenopausal women a safety perspective.

Authors:  E Robinson; G G Kimmick; H B Muss
Journal:  Drugs Aging       Date:  1996-05       Impact factor: 3.923

2.  Tamoxifen inhibits acidification in cells independent of the estrogen receptor.

Authors:  N Altan; Y Chen; M Schindler; S M Simon
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

Review 3.  Tamoxifen and secondary tumours. An update.

Authors:  N Wilking; E Isaksson; E von Schoultz
Journal:  Drug Saf       Date:  1997-02       Impact factor: 5.606

Review 4.  Third annual William L. McGuire Memorial Lecture. "Studies on the estrogen receptor in breast cancer"--20 years as a target for the treatment and prevention of cancer.

Authors:  V C Jordan
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

5.  Downregulation of GLUT4 contributes to effective intervention of estrogen receptor-negative/HER2-overexpressing early stage breast disease progression by lapatinib.

Authors:  Sunil Acharya; Jia Xu; Xiao Wang; Shalini Jain; Hai Wang; Qingling Zhang; Chia-Chi Chang; Joseph Bower; Banu Arun; Victoria Seewaldt; Dihua Yu
Journal:  Am J Cancer Res       Date:  2016-05-01       Impact factor: 6.166

6.  Retinal function in patients treated with tamoxifen.

Authors:  Sung Eun Song Watanabe; Adriana Berezovsky; Márcia Motono; Paula Yuri Sacai; Josenilson Martins Pereira; Juliana Maria Ferraz Sallum; Luiz Henrique Gebrim; Solange Rios Salomão
Journal:  Doc Ophthalmol       Date:  2010-04       Impact factor: 2.379

7.  Activation of the steroid and xenobiotic receptor, SXR, induces apoptosis in breast cancer cells.

Authors:  Suman Verma; Michelle M Tabb; Bruce Blumberg
Journal:  BMC Cancer       Date:  2009-01-05       Impact factor: 4.430

8.  Boosting immune surveillance by low-dose PI3K inhibitor facilitates early intervention of breast cancer.

Authors:  Jinyang Wang; Yuan Zhang; Yi Xiao; Xiangliang Yuan; Ping Li; Xiao Wang; Yimin Duan; Victoria L Seewaldt; Dihua Yu
Journal:  Am J Cancer Res       Date:  2021-05-15       Impact factor: 6.166
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.